Drug Topics April 2023

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.

Daprodustat increases erythropoietin production, leading to an increase in the production of red blood cells.

Despite a massive COVID-19 vaccination campaign, many still fear a return to normal.

From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.

Pharmacists need a depth and breadth of knowledge to get the most out of point-of-care testing for sexually transmitted infections.

As more adalimumab biosimilars are poised to enter the market, manufacturers, payers, and patient advocates are preparing to navigate potentially turbulent waters.

Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.

Vaccine hesitancy exists on a spectrum, but with the right tools, pharmacists can provide education and reassurance to parents and caregivers.

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.

The CGM provides accurate readings over 10.5 days of continuous wear.

Rates of xylazine use have skyrocketed in since 2010, leading to an increase in overdoses and death.

Nerivio received clearance in January 2021 for use in acute migraine.

Keeping inventory always comes with various costs. How do pharmacies approach these obstacles?

The number of digital therapeutics available for migraine is likely to expand.